A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion - PubMed (original) (raw)
. 2007 Jun 1;195(11):1582-9.
doi: 10.1086/516784. Epub 2007 Apr 16.
Affiliations
- PMID: 17471427
- DOI: 10.1086/516784
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion
Martyn Plummer et al. J Infect Dis. 2007.
Abstract
Background: Cervical cancer is caused by persistent infection with human papillomavirus (HPV). Most infections and associated lesions clear spontaneously. It is important to define the determinants and timing of clearance, so that viral persistence can be recognized and managed.
Methods: We investigated HPV natural history among 4504 subjects from ALTS (Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study). A discrete-time Markov model was used to simultaneously describe the prevalence, incidence, and persistence of type-specific HPV infection over 24 months in women with equivocal or mildly abnormal cytological results. Interactions between multiple HPV types infecting the same woman were examined for incidence of new infection (after an HPV-16 infection) and persistence of a current infection within groups defined by phylogenetic relatedness or by carcinogenicity.
Results: Ninety-one percent (95% credible interval [CI], 90%-92%) of prevalent HPV infections at enrollment cleared within 24 months. The probability that an infection would persist for a further 6 months increased with the duration of infection, from 37% (95% CI, 35%-39%) for a newly observed infection to 65% (95% CI, 61%-70%) for an infection that had already persisted for > or =18 months. No consistent evidence of interactions was found between multiple HPV types regarding the incidence of new infection after an HPV-16 infection or regarding persistence of current HPV infection.
Conclusion: Although virtually all HPV infections clear within 2 years, the remaining infections have a high potential for persistence and, by implication, progression to precancer and cancer. Once biological and behavioral determinants are controlled for, HPV infections with different types seem to be independent of each other.
Comment in
Similar articles
- Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE; ASCUS-LSIL Triage Study Group. Kreimer AR, et al. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):11-6. doi: 10.1158/1055-9965.EPI-06-0710. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17220326 - [Role of high-risk human papillomavirus testing in the screening and management of cervical cancer precursors].
Jin Y, Pan LY. Jin Y, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):691-6. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007. PMID: 18051730 Review. Chinese. - Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.
Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M. Verdoodt F, et al. Cancer Cytopathol. 2013 Dec;121(12):675-87. doi: 10.1002/cncy.21325. Epub 2013 Jul 23. Cancer Cytopathol. 2013. PMID: 23881840 Review.
Cited by
- Global pattern of persistent human papillomavirus infection in female genital tract: An update system review and meta-analysis.
Zhao M, Kang P, Zhu L, Zhou D, Cui M, Zhang M, Jia J, Luo L. Zhao M, et al. iScience. 2024 Sep 19;27(10):110991. doi: 10.1016/j.isci.2024.110991. eCollection 2024 Oct 18. iScience. 2024. PMID: 39474077 Free PMC article. - Inferring the natural history of HPV from global cancer registries: insights from a multi-country calibration.
Stuart RM, Cohen JA, Abeysuriya RG, Sanz-Leon P, Kerr CC, Rao D, Klein DJ. Stuart RM, et al. Sci Rep. 2024 Jul 10;14(1):15875. doi: 10.1038/s41598-024-65842-3. Sci Rep. 2024. PMID: 38982088 Free PMC article. - Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
Feng T, Cheng B, Sun W, Yang Y. Feng T, et al. BMC Womens Health. 2023 Nov 14;23(1):599. doi: 10.1186/s12905-023-02764-8. BMC Womens Health. 2023. PMID: 37957634 Free PMC article. - Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.
Peng G, Dan W, Jun W, Junjun Y, Tong R, Baoli Z, Yang X. Peng G, et al. Tumour Biol. 2015 May;36(5):3309-17. doi: 10.1007/s13277-014-2963-0. Epub 2015 Jan 14. Tumour Biol. 2015. PMID: 25586346 - Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction.
Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, Bernstein DI. Kahn JA, et al. Pediatrics. 2012 Aug;130(2):e249-56. doi: 10.1542/peds.2011-3587. Epub 2012 Jul 9. Pediatrics. 2012. PMID: 22778297 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- CN55105/CN/NCI NIH HHS/United States
- CN55153/CN/NCI NIH HHS/United States
- CN55154/CN/NCI NIH HHS/United States
- CN55155/CN/NCI NIH HHS/United States
- CN55156/CN/NCI NIH HHS/United States
- CN55157/CN/NCI NIH HHS/United States
- CN55158/CN/NCI NIH HHS/United States
- CN55159/CN/NCI NIH HHS/United States
- Intramural NIH HHS/United States